Abivax SA American Depositary Shares (ABVX : NASDAQ)
Common Stock
$84.17
USD
-5.31 (-5.94%)
Last updated: 2026-11-05
Follow ABVX
ABVX
Abivax SA American Depositary Shares
WealthAwesomePerformance
1 Day
+0.88%
1 Week
-0.39%
1 Month
-2.44%
YTD
-10.64%
Key Statistics
Market Cap
$7.37B
52W High
$148.83
52W Low
$69.81
P/E Ratio
-
50 Day MA
$98.42
200 Day MA
$113.65
Beta
-0.34
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/5/2026 | $91.24 | $91.32 | $83.77 | $84.17 | $84.17 | 1,232,779 |
| 11/4/2026 | $90.39 | $90.87 | $87.78 | $89.49 | $89.49 | 568,082 |
| 11/3/2026 | $85.37 | $90.12 | $85.26 | $88.71 | $88.71 | 585,019 |
| 11/2/2026 | $87.32 | $87.50 | $83.55 | $84.91 | $84.91 | 730,296 |
| 10/30/2026 | $87.66 | $88.90 | $85.81 | $86.59 | $86.59 | 842,500 |
| 10/29/2026 | $89.85 | $92.09 | $88.39 | $89.06 | $89.06 | 594,808 |
| 10/28/2026 | $87.91 | $90.98 | $87.03 | $89.84 | $89.84 | 533,423 |
| 10/27/2026 | $86.63 | $89.40 | $86.14 | $87.00 | $87.00 | 740,185 |
| 10/26/2026 | $88.01 | $88.46 | $86.25 | $86.50 | $86.50 | 423,692 |
| 10/23/2026 | $89.60 | $89.60 | $87.03 | $88.01 | $88.01 | 432,500 |
Analyst Price Targets
Based on 12 analysts covering ABVX · as of Oct 14, 2026
Wall Street analysts forecast ABVX stock price to rise 94.3% over the next 12 months.
Consensus
Strong Buy4.67 / 5.00
Avg. Target
US$163.58
+94.3% Upside
Previously US$164.00 on Oct 5, 2026
Current Price
US$84.17
Last close
Analyst Breakdown (12 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ABVX's historical volatility
30-Day Vol
50.1%
Annualized
90-Day Vol
45.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$70.41
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$79.31 | US$66.72 – US$94.27 |
| 60 trading days | US$74.73 | US$58.52 – US$95.42 |
| 90 trading days | US$70.41 | US$52.19 – US$94.98 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Abivax SA American Depositary Shares
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Financials
- Revenue (TTM)
- $4.67M
- EBITDA
- $-291.55M
- Profit Margin
- 0.00%
- ROE (TTM)
- -252.35%
- EPS (Diluted)
- -5.70
- Book Value
- 5.16
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About ABVX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| INM | InMed Pharmaceuticals Inc | $17.50 | +941.67% |
| OMH | Ohmyhome Limited Ordinary Shares | $15.55 | +432.53% |
| CRIS | Curis Inc | $1.11 | +56.34% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.04 | +54.07% |
| RFAIR | RF Acquisition Corp II Right | $0.24 | +50.00% |
| CRCT | Cricut Inc | $8.88 | +48.74% |
| LYEL | Lyell Immunopharma Inc | $15.43 | +43.27% |
| GENVR | Gen Digital Inc. Contingent Value Rights | $4.03 | +42.40% |
ABVX.US news timeline
1 article covering ABVX.US, most recent first
Latest